{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:06Z","timestamp":1791331206561,"version":"4.3.1"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s11940-017-0443-8","type":"journal-article","created":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T07:19:46Z","timestamp":1488352786000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["New Assessments and Treatments in ASD"],"prefix":"10.1007","volume":"19","author":[{"given":"Roula N.","family":"Choueiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew W.","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,1]]},"reference":[{"key":"443_CR1","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Publishing; 2013.","edition":"5"},{"issue":"4","key":"443_CR2","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1212\/WNL.55.4.468","volume":"55","author":"PA Filipek","year":"2000","unstructured":"\u2022\u2022 Filipek PA, Accardo PJ, Ashwal S, Baranek GT, Cook Jr EH, Dawson G, et al. Practice parameter: screening and diagnosis of autism: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Child Neurology Society. Neurology. 2000;55(4):468\u201379. This papers are important as clinical parameters to follow in the assesment of ASD.","journal-title":"Neurology"},{"issue":"5","key":"443_CR3","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1542\/peds.2007-2361","volume":"120","author":"CP Johnson","year":"2007","unstructured":"\u2022\u2022 Johnson CP, Myers SM. American Academy of Pediatrics Council on Children With Disabilities. Identification and evaluation of children with autism spectrum disorders. Pediatrics. 2007;120(5):1183\u2013215. doi: 10.1542\/peds.2007-2361 . This papers are important as clinical parameters to follow in the assessment of ASD.","journal-title":"Pediatrics"},{"key":"443_CR4","unstructured":"Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2010. Developmental Disabilities Monitoring Network Surveillance Year 2010 Principal Investigators; Centers for Disease Control and Prevention (CDC). MMWR Surveill Summ. 2014 Mar 28;63(2):1\u201321."},{"issue":"12","key":"443_CR5","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1007\/s10803-013-1831-x","volume":"43","author":"AM Daniels","year":"2013","unstructured":"\u2022 Daniels AM, Mandell DS. Children\u2019s compliance with American Academy of Pediatrics\u2019 well-child care visit guidelines and the early detection of autism. J Autism Dev Disord. 2013;43(12):2844\u201354. doi: 10.1007\/s10803-013-1831-x . This paper emphasizes the importance of screening and compliance with AAP guidelines.","journal-title":"J Autism Dev Disord"},{"issue":"1","key":"443_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1542\/peds.2013-1813","volume":"133","author":"DL Robins","year":"2014","unstructured":"Robins DL, Casagrande K, Barton M, Chen CM, Dumont-Mathieu T, Fein D. Validation of the modified checklist for Autism in toddlers, revised with follow-up (M-CHAT-R\/F). Pediatrics. 2014;133(1):37\u201345. doi: 10.1542\/peds.2013-1813 .","journal-title":"Pediatrics"},{"issue":"4","key":"443_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1177\/1362361306066612","volume":"10","author":"J Williams","year":"2006","unstructured":"Williams J, Allison C, Scott F, Stott C, Bolton P, Baron-Cohen S, et al. The Childhood Asperger Syndrome Test (CAST): test-retest reliability. Autism. 2006;10(4):415\u201327. doi: 10.1177\/1362361306066612 .","journal-title":"Autism"},{"issue":"10","key":"443_CR8","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1097\/chi.0b013e31812f7d8d","volume":"46","author":"S Chandler","year":"2007","unstructured":"Chandler S, Charman T, Baird G, Simonoff E, Loucas T, Meldrum D, et al. Validation of the social communication questionnaire in a population cohort of children with autism spectrum disorders. J Am Acad Child Adolesc Psychiatry. 2007;46(10):1324\u201332. doi: 10.1097\/chi.0b013e31812f7d8d .","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"443_CR9","volume-title":"Autism diagnostic interview\u2014revised","author":"ML Rutter","year":"2003","unstructured":"Rutter ML, Le Couteur A, Lord C. Autism diagnostic interview\u2014revised. Los Angeles: Western Psychological Services; 2003."},{"issue":"4","key":"443_CR10","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1023\/A:1025014929212","volume":"33","author":"JN Constantino","year":"2003","unstructured":"Constantino JN, Davis SA, Todd RD, Schindler MK, Gross MM, Brophy SL, et al. Validation of a brief quantitative measure of autistic traits: comparison of the social responsiveness scale with the autism diagnostic interview-revised. J Autism Dev Disord. 2003;33(4):427\u201333.","journal-title":"J Autism Dev Disord"},{"key":"443_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s10803-016-2936-9","author":"E Moulton","year":"2016","unstructured":"Moulton E, Bradbury K, Barton M, Fein D. Factor analysis of the childhood autism rating scale in a sample of two year olds with an autism spectrum disorder. J Autism Dev Disord. 2016. doi: 10.1007\/s10803-016-2936-9 .","journal-title":"J Autism Dev Disord"},{"key":"443_CR12","doi-asserted-by":"publisher","first-page":"8243079","DOI":"10.1155\/2016\/8243079","volume":"2016","author":"MA Volker","year":"2016","unstructured":"Volker MA, Dua EH, Lopata C, Thomeer ML, Toomey JA, Smerbeck AM, et al. Factor structure, internal consistency, and screening sensitivity of the GARS-2 in a developmental disabilities sample. Autism Res Treat. 2016;2016:8243079. doi: 10.1155\/2016\/8243079 .","journal-title":"Autism Res Treat"},{"issue":"6","key":"443_CR13","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s10803-004-5289-8","volume":"34","author":"WL Stone","year":"2004","unstructured":"Stone WL, Coonrod EE, Turner LM, Pozdol SL. Psychometric properties of the STAT for early autism screening. J Autism Dev Disord. 2004;34(6):691\u2013701.","journal-title":"J Autism Dev Disord"},{"issue":"2","key":"443_CR14","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.jpeds.2015.05.029","volume":"167","author":"R Choueiri","year":"2015","unstructured":"Choueiri R, Wagner S. A New interactive screening test for autism spectrum disorders in toddlers. J Pediatr. 2015;167(2):460\u20136. doi: 10.1016\/j.jpeds.2015.05.029 .","journal-title":"J Pediatr"},{"key":"443_CR15","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: American Psychiatric Publishing; 2000."},{"issue":"6","key":"443_CR16","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1007\/s10803-016-2734-4","volume":"46","author":"JA Christiansz","year":"2016","unstructured":"Christiansz JA, Gray KM, Taffe J, Tonge BJ. Autism spectrum disorder in the DSM-5: diagnostic sensitivity and specificity in early childhood. J Autism Dev Disord. 2016;46(6):2054\u201363. doi: 10.1007\/s10803-016-2734-4 .","journal-title":"J Autism Dev Disord"},{"issue":"8","key":"443_CR17","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1007\/s10803-014-2065-2","volume":"44","author":"KM Kulage","year":"2014","unstructured":"\u2022\u2022 Kulage KM, Smaldone AM, Cohn EG. How will DSM-5 affect autism diagnosis? A systematic literature review and meta-analysis. J Autism Dev Disord. 2014;44(8):1918\u201332. doi: 10.1007\/s10803-014-2065-2 . An important review of DSM 5 changes and practice.","journal-title":"J Autism Dev Disord"},{"key":"443_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1146\/annurev-clinpsy-032814-112745","volume":"11","author":"C Lord","year":"2015","unstructured":"\u2022\u2022 Lord C, Bishop SL. Recent advances in autism research as reflected in DSM-5 criteria for autism spectrum disorder. Annu Rev Clin Psychol. 2015;11:53\u201370. doi: 10.1146\/annurev-clinpsy-032814-112745 . An important review of DSM 5 changes and research.","journal-title":"Annu Rev Clin Psychol"},{"key":"443_CR19","volume-title":"Autism Diagnostic Observation Schedule (ADOS) manual","author":"C Lord","year":"2001","unstructured":"Lord C, Rutter ML, DiLavore P, Risi S. Autism Diagnostic Observation Schedule (ADOS) manual. Los Angeles: Western Psychological Services; 2001."},{"issue":"9","key":"443_CR20","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/s10803-009-0746-z","volume":"39","author":"R Luyster","year":"2009","unstructured":"Luyster R, Gotham K, Guthrie W, Coffing M, Petrak R, Pierce K, et al. The Autism Diagnostic Observation Schedule-toddler module: a new module of a standardized diagnostic measure for autism spectrum disorders. J Autism Dev Disord. 2009;39(9):1305\u201320. doi: 10.1007\/s10803-009-0746-z .","journal-title":"J Autism Dev Disord"},{"issue":"8","key":"443_CR21","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.jaac.2013.05.004","volume":"52","author":"W Guthrie","year":"2013","unstructured":"Guthrie W, Swineford LB, Wetherby AM, Lord C. Comparison of DSM-IV and DSM-5 factor structure models for toddlers with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry. 2013;52(8):797\u2013805 e2. doi: 10.1016\/j.jaac.2013.05.004 .","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"5","key":"443_CR22","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1007\/s10803-014-2299-z","volume":"45","author":"RC Schaaf","year":"2015","unstructured":"Schaaf RC, Lane AE. Toward a best-practice protocol for assessment of sensory features in ASD. J Autism Dev Disord. 2015;45(5):1380\u201395. doi: 10.1007\/s10803-014-2299-z .","journal-title":"J Autism Dev Disord"},{"key":"443_CR23","volume-title":"Sensory Processing Measure (SPM)\u2014Home Form","author":"H Miller-Kuhaneck","year":"2010","unstructured":"Miller-Kuhaneck H, Henry D, Glennon T. Sensory Processing Measure (SPM)\u2014Home Form. Torrance: Western Psychological Services; 2010."},{"key":"443_CR24","volume-title":"Sensory profile: adolescent\/adult sensory profile","author":"W Dunn","year":"2002","unstructured":"Dunn W. Sensory profile: adolescent\/adult sensory profile. San Antonio: Pearson Assessments; 2002."},{"issue":"6","key":"443_CR25","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1542\/peds.2012-0876","volume":"129","author":"C Section On","year":"2012","unstructured":"\u2022\u2022 Section On C, Integrative M. Council on Children with D, American Academy of P, Zimmer M, Desch L. Sensory integration therapies for children with developmental and behavioral disorders. Pediatrics. 2012;129(6):1186\u20139. doi: 10.1542\/peds.2012-0876 . Recommendations from the AAP on sensory based therapies.","journal-title":"Pediatrics"},{"issue":"4","key":"443_CR26","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s10803-012-1621-x","volume":"43","author":"BD Barger","year":"2013","unstructured":"Barger BD, Campbell JM, McDonough JD. Prevalence and onset of regression within autism spectrum disorders: a meta-analytic review. J Autism Dev Disord. 2013;43(4):817\u201328. doi: 10.1007\/s10803-012-1621-x .","journal-title":"J Autism Dev Disord"},{"issue":"1","key":"443_CR27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/jpc.12805","volume":"51","author":"K Williams","year":"2015","unstructured":"Williams K, Brignell A, Prior M, Bartak L, Roberts J. Regression in autism spectrum disorders. J Paediatr Child Health. 2015;51(1):61\u20134. doi: 10.1111\/jpc.12805 .","journal-title":"J Paediatr Child Health"},{"key":"443_CR28","doi-asserted-by":"crossref","unstructured":"Sparrow SS, Balla DA, Cicchetti DV. Vineland Adaptive Behavior Scales Second Edition Survey Forms Manual. AGS Publishing; 2005.","DOI":"10.1037\/t15164-000"},{"issue":"3","key":"443_CR29","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1207\/s15374424jccp3403_8","volume":"34","author":"S Ozonoff","year":"2005","unstructured":"Ozonoff S, Goodlin-Jones BL, Solomon M. Evidence-based assessment of autism spectrum disorders in children and adolescents. J Clin Child Adolesc Psychol. 2005;34(3):523\u201340. doi: 10.1207\/s15374424jccp3403_8 .","journal-title":"J Clin Child Adolesc Psychol"},{"issue":"2","key":"443_CR30","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/apa.13243","volume":"105","author":"S Bolte","year":"2016","unstructured":"Bolte S, Bartl-Pokorny KD, Jonsson U, Berggren S, Zhang D, Kostrzewa E, et al. How can clinicians detect and treat autism early? Methodological trends of technology use in research. Acta Paediatr. 2016;105(2):137\u201344. doi: 10.1111\/apa.13243 .","journal-title":"Acta Paediatr"},{"key":"443_CR31","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ridd.2014.11.019","volume":"37","author":"C Daluwatte","year":"2015","unstructured":"\u2022 Daluwatte C, Miles JH, Sun J, Yao G. Association between pupillary light reflex and sensory behaviors in children with autism spectrum disorders. Res Dev Disabil. 2015;37:209\u201315. doi: 10.1016\/j.ridd.2014.11.019 . This paper outlines the basis for differences in the pupillary light reflex in ASD.","journal-title":"Res Dev Disabil"},{"issue":"1","key":"443_CR32","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13229-016-0098-4","volume":"7","author":"HJ Nuske","year":"2016","unstructured":"Nuske HJ, Vivanti G, Dissanayake C. Others\u2019 emotions teach, but not in autism: an eye-tracking pupillometry study. Mol Autism. 2016;7(1):36. doi: 10.1186\/s13229-016-0098-4 .","journal-title":"Mol Autism"},{"issue":"2","key":"443_CR33","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.braindev.2015.07.003","volume":"38","author":"X Ming","year":"2016","unstructured":"\u2022\u2022 Ming X, Patel R, Kang V, Chokroverty S, Julu PO. Respiratory and autonomic dysfunction in children with autism spectrum disorders. Brain Dev. 2016;38(2):225\u201332. doi: 10.1016\/j.braindev.2015.07.003 . This is a useful review of autonomic testing and dysfunction in ASD.","journal-title":"Brain Dev"},{"key":"443_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/aur.1646","author":"BJ Ferguson","year":"2016","unstructured":"Ferguson BJ, Marler S, Altstein LL, Lee EB, Akers J, Sohl K, et al. Psychophysiological associations with gastrointestinal symptomatology in autism spectrum disorder. Autism Res. 2016. doi: 10.1002\/aur.1646 .","journal-title":"Autism Res"},{"issue":"1","key":"443_CR35","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s10484-015-9311-z","volume":"41","author":"Y Wang","year":"2016","unstructured":"Wang Y, Hensley MK, Tasman A, Sears L, Casanova MF, Sokhadze EM. Heart rate variability and skin conductance during repetitive TMS course in children with autism. Appl Psychophysiol Biofeedback. 2016;41(1):47\u201360. doi: 10.1007\/s10484-015-9311-z .","journal-title":"Appl Psychophysiol Biofeedback"},{"issue":"7","key":"443_CR36","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1089\/cap.2015.0166","volume":"26","author":"LM Oberman","year":"2016","unstructured":"Oberman LM, Ifert-Miller F, Najib U, Bashir S, Heydrich JG, Picker J, et al. Abnormal mechanisms of plasticity and metaplasticity in autism spectrum disorders and fragile X syndrome. J Child Adolesc Psychopharmacol. 2016;26(7):617\u201324. doi: 10.1089\/cap.2015.0166 .","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"2","key":"443_CR37","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/aur.1567","volume":"9","author":"LM Oberman","year":"2016","unstructured":"\u2022 Oberman LM, Enticott PG, Casanova MF, Rotenberg A, Pascual-Leone A, McCracken JT, et al. Transcranial magnetic stimulation in autism spectrum disorder: challenges, promise, and roadmap for future research. Autism Res. 2016;9(2):184\u2013203. doi: 10.1002\/aur.1567 . This paper is a helpful review of TMS in ASD.","journal-title":"Autism Res"},{"key":"443_CR38","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neubiorev.2015.02.002","volume":"52","author":"NR Zurcher","year":"2015","unstructured":"Zurcher NR, Bhanot A, McDougle CJ, Hooker JM. A systematic review of molecular imaging (PET and SPECT) in autism spectrum disorder: current state and future research opportunities. Neurosci Biobehav Rev. 2015;52:56\u201373. doi: 10.1016\/j.neubiorev.2015.02.002 .","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"443_CR39","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.pcl.2011.10.002","volume":"59","author":"DC Chugani","year":"2012","unstructured":"Chugani DC. Neuroimaging and neurochemistry of autism. Pediatr Clin North Am. 2012;59(1):63\u201373. doi: 10.1016\/j.pcl.2011.10.002 .","journal-title":"Pediatr Clin North Am"},{"key":"443_CR40","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3389\/fnhum.2016.00211","volume":"10","author":"MM Ismail","year":"2016","unstructured":"\u2022 Ismail MM, Keynton RS, Mostapha MM, ElTanboly AH, Casanova MF, Gimel\u2019farb GL, et al. Studying autism spectrum disorder with structural and diffusion magnetic resonance imaging: a survey. Front Hum Neurosci. 2016;10:211. doi: 10.3389\/fnhum.2016.00211 . This is a good review of recent techniques using MRI for research in ASD.","journal-title":"Front Hum Neurosci"},{"issue":"6","key":"443_CR41","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1007\/s10803-016-2744-2","volume":"46","author":"VM Vogan","year":"2016","unstructured":"Vogan VM, Morgan BR, Leung RC, Anagnostou E, Doyle-Thomas K, Taylor MJ. Widespread white matter differences in children and adolescents with autism spectrum disorder. J Autism Dev Disord. 2016;46(6):2138\u201347. doi: 10.1007\/s10803-016-2744-2 .","journal-title":"J Autism Dev Disord"},{"issue":"1","key":"443_CR42","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s11682-013-9245-0","volume":"8","author":"RM Joseph","year":"2014","unstructured":"Joseph RM, Fricker Z, Fenoglio A, Lindgren KA, Knaus TA, Tager-Flusberg H. Structural asymmetries of language-related gray and white matter and their relationship to language function in young children with ASD. Brain Imaging Behav. 2014;8(1):60\u201372. doi: 10.1007\/s11682-013-9245-0 .","journal-title":"Brain Imaging Behav"},{"issue":"4","key":"443_CR43","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00787-015-0746-9","volume":"25","author":"G Valvo","year":"2016","unstructured":"Valvo G, Baldini S, Retico A, Rossi G, Tancredi R, Ferrari AR, et al. Temporal lobe connects regression and macrocephaly to autism spectrum disorders. Eur Child Adolesc Psychiatry. 2016;25(4):421\u20139. doi: 10.1007\/s00787-015-0746-9 .","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"443_CR44","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12883-015-0355-8","volume":"15","author":"S Matlis","year":"2015","unstructured":"Matlis S, Boric K, Chu CJ, Kramer MA. Robust disruptions in electroencephalogram cortical oscillations and large-scale functional networks in autism. BMC Neurol. 2015;15:97. doi: 10.1186\/s12883-015-0355-8 .","journal-title":"BMC Neurol"},{"key":"443_CR45","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.pediatrneurol.2016.03.010","volume":"61","author":"TM Heunis","year":"2016","unstructured":"\u2022 Heunis TM, Aldrich C, de Vries PJ. Recent advances in resting-state electroencephalography biomarkers for autism spectrum disorder-a review of methodological and clinical challenges. Pediatr Neurol. 2016;61:28\u201337. doi: 10.1016\/j.pediatrneurol.2016.03.010 . This review covers advances in EEG in the field of ASD.","journal-title":"Pediatr Neurol"},{"issue":"2","key":"443_CR46","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/pcn.12338","volume":"70","author":"M Kikuchi","year":"2016","unstructured":"Kikuchi M, Yoshimura Y, Mutou K, Minabe Y. Magnetoencephalography in the study of children with autism spectrum disorder. Psychiatry Clin Neurosci. 2016;70(2):74\u201388. doi: 10.1111\/pcn.12338 .","journal-title":"Psychiatry Clin Neurosci"},{"key":"443_CR47","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3389\/fnins.2016.00258","volume":"10","author":"M Datko","year":"2016","unstructured":"Datko M, Gougelet R, Huang MX, Pineda JA. Resting state functional connectivity MRI among spectral MEG current sources in children on the autism spectrum. Front Neurosci. 2016;10:258. doi: 10.3389\/fnins.2016.00258 .","journal-title":"Front Neurosci"},{"key":"443_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/aur.1686","author":"RG Port","year":"2016","unstructured":"\u2022\u2022 Port RG, Gaetz W, Bloy L, Wang DJ, Blaskey L, Kuschner ES, et al. Exploring the relationship between cortical GABA concentrations, auditory gamma-band responses and development in ASD: Evidence for an altered maturational trajectory in ASD. Autism Res. 2016. doi: 10.1002\/aur.1686 . This unique study explores excitatory\/inhibitory imbalance in ASD using both MEG and MRS.","journal-title":"Autism Res"},{"key":"443_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2012.124","volume":"2","author":"E Lemonnier","year":"2012","unstructured":"\u2022 Lemonnier E, Degrez C, Phelep M, Tyzio R, Josse F, Grandgeorge M, et al. A randomised controlled trial of bumetanide in the treatment of autism in children. Transl Psychiatry. 2012;2, e202. doi: 10.1038\/tp.2012.124 . In this paper, the basis for the use of bumetanide is outlined in a well controlled clinical trial.","journal-title":"Transl Psychiatry"},{"issue":"7397","key":"443_CR50","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/nature10989","volume":"485","author":"BJ O\u2019Roak","year":"2012","unstructured":"O\u2019Roak BJ, Vives L, Girirajan S, Karakoc E, Krumm N, Coe BP, et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature. 2012;485(7397):246\u201350. doi: 10.1038\/nature10989 .","journal-title":"Nature"},{"issue":"1","key":"443_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2040-2392-2-1","volume":"2","author":"JP Hussman","year":"2011","unstructured":"Hussman JP, Chung RH, Griswold AJ, Jaworski JM, Salyakina D, Ma D, et al. A noise-reduction GWAS analysis implicates altered regulation of neurite outgrowth and guidance in autism. Mol Autism. 2011;2(1):1. doi: 10.1186\/2040-2392-2-1 .","journal-title":"Mol Autism"},{"issue":"2","key":"443_CR52","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.tins.2013.11.005","volume":"37","author":"N Krumm","year":"2014","unstructured":"Krumm N, O\u2019Roak BJ, Shendure J, Eichler EE. A de novo convergence of autism genetics and molecular neuroscience. Trends Neurosci. 2014;37(2):95\u2013105. doi: 10.1016\/j.tins.2013.11.005 .","journal-title":"Trends Neurosci"},{"key":"443_CR53","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s40142-016-0099-9","volume":"4","author":"B Finucane","year":"2016","unstructured":"Finucane B, Myers SM. Genetic counseling for autism spectrum disorder in an evolving theoretical landscape. Curr Genet Med Rep. 2016;4:147\u201353. doi: 10.1007\/s40142-016-0099-9 .","journal-title":"Curr Genet Med Rep"},{"issue":"4","key":"443_CR54","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nm.4071","volume":"22","author":"L Torre-Ubieta de la","year":"2016","unstructured":"\u2022 de la Torre-Ubieta L, Won H, Stein JL, Geschwind DH. Advancing the understanding of autism disease mechanisms through genetics. Nat Med. 2016;22(4):345\u201361. doi: 10.1038\/nm.4071 . A comprehensive and thoughtful paper, the authors outline current advances in genetics of ASD.","journal-title":"Nat Med"},{"issue":"7351","key":"443_CR55","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nature10110","volume":"474","author":"I Voineagu","year":"2011","unstructured":"Voineagu I, Wang X, Johnston P, Lowe JK, Tian Y, Horvath S, et al. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature. 2011;474(7351):380\u20134. doi: 10.1038\/nature10110 .","journal-title":"Nature"},{"issue":"5","key":"443_CR56","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/gim.2013.32","volume":"15","author":"GB Schaefer","year":"2013","unstructured":"Schaefer GB, Mendelsohn NJ, Professional P, Guidelines C. Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions. Genet Med. 2013;15(5):399\u2013407. doi: 10.1038\/gim.2013.32 .","journal-title":"Genet Med"},{"issue":"1","key":"443_CR57","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/dmcn.12278","volume":"56","author":"RO Rosti","year":"2014","unstructured":"Rosti RO, Sadek AA, Vaux KK, Gleeson JG. The genetic landscape of autism spectrum disorders. Dev Med Child Neurol. 2014;56(1):12\u20138. doi: 10.1111\/dmcn.12278 .","journal-title":"Dev Med Child Neurol"},{"key":"443_CR58","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.neubiorev.2016.06.013","volume":"68","author":"JY An","year":"2016","unstructured":"\u2022\u2022 An JY, Claudianos C. Genetic heterogeneity in autism: from single gene to a pathway perspective. Neurosci Biobehav Rev. 2016;68:442\u201353. doi: 10.1016\/j.neubiorev.2016.06.013 . This important paper advances conceptual thinking about a \u201cpathway perspective\u201d in ASD.","journal-title":"Neurosci Biobehav Rev"},{"issue":"7\u20138","key":"443_CR59","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.crvi.2016.05.004","volume":"339","author":"T Bourgeron","year":"2016","unstructured":"Bourgeron T. Current knowledge on the genetics of autism and propositions for future research. C R Biol. 2016;339(7\u20138):300\u20137. doi: 10.1016\/j.crvi.2016.05.004 .","journal-title":"C R Biol"},{"issue":"4","key":"443_CR60","doi-asserted-by":"publisher","first-page":"301","DOI":"10.5607\/en.2015.24.4.301","volume":"24","author":"O Penagarikano","year":"2015","unstructured":"\u2022\u2022 Penagarikano O. New therapeutic options for autism spectrum disorder: experimental evidences. Exp Neurobiol. 2015;24(4):301\u201311. doi: 10.5607\/en.2015.24.4.301 . Useful approach to exploration of therapeutic options for ASD is outlined in this paper.","journal-title":"Exp Neurobiol"},{"issue":"Suppl 2","key":"443_CR61","doi-asserted-by":"publisher","first-page":"S124","DOI":"10.1542\/peds.2015-2851K","volume":"137","author":"LK Fung","year":"2016","unstructured":"Fung LK, Mahajan R, Nozzolillo A, Bernal P, Krasner A, Jo B, et al. Pharmacologic treatment of severe irritability and problem behaviors in autism: a systematic review and meta-analysis. Pediatrics. 2016;137 Suppl 2:S124\u201335. doi: 10.1542\/peds.2015-2851K .","journal-title":"Pediatrics"},{"issue":"2","key":"443_CR62","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/YCO.0000000000000132","volume":"28","author":"N Ji","year":"2015","unstructured":"\u2022 Ji N, Findling RL. An update on pharmacotherapy for autism spectrum disorder in children and adolescents. Curr Opin Psychiatry. 2015;28(2):91\u2013101. doi: 10.1097\/YCO.0000000000000132 . This is a well written paper by knowledgeable authors on use of medications for ASD.","journal-title":"Curr Opin Psychiatry"},{"issue":"12","key":"443_CR63","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1176\/appi.ajp.2015.15010055","volume":"172","author":"L Scahill","year":"2015","unstructured":"Scahill L, McCracken JT, King BH, Rockhill C, Shah B, Politte L, et al. Extended-release guanfacine for hyperactivity in children with autism spectrum disorder. Am J Psychiatry. 2015;172(12):1197\u2013206. doi: 10.1176\/appi.ajp.2015.15010055 .","journal-title":"Am J Psychiatry"},{"issue":"11","key":"443_CR64","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.jaac.2015.08.013","volume":"54","author":"BL Handen","year":"2015","unstructured":"\u2022 Handen BL, Aman MG, Arnold LE, Hyman SL, Tumuluru RV, Lecavalier L, et al. Atomoxetine, parent training, and their combination in children with autism spectrum disorder and attention-deficit\/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2015;54(11):905\u201315. doi: 10.1016\/j.jaac.2015.08.013 . A unique approach is offered in this paper: combining parent training with a medication.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"443_CR65","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/sj.npp.1300627","volume":"30","author":"E Hollander","year":"2005","unstructured":"Hollander E, Phillips A, Chaplin W, Zagursky K, Novotny S, Wasserman S, et al. A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacology. 2005;30(3):582\u20139. doi: 10.1038\/sj.npp.1300627 .","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"443_CR66","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1001\/archgenpsychiatry.2009.30","volume":"66","author":"BH King","year":"2009","unstructured":"King BH, Hollander E, Sikich L, McCracken JT, Scahill L, Bregman JD, et al. Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism. Arch Gen Psychiatry. 2009;66(6):583\u201390. doi: 10.1001\/archgenpsychiatry.2009.30 .","journal-title":"Arch Gen Psychiatry"},{"key":"443_CR67","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jpeds.2015.11.033","volume":"170","author":"DC Chugani","year":"2016","unstructured":"\u2022 Chugani DC, Chugani HT, Wiznitzer M, Parikh S, Evans PA, Hansen RL, et al. Efficacy of low-dose buspirone for restricted and repetitive behavior in young children with autism spectrum disorder: a randomized trial. J Pediatr. 2016;170:45\u201353.e1-4. doi: 10.1016\/j.jpeds.2015.11.033 . This is a landmark study of serotonergic therapy in young children with ASD.","journal-title":"J Pediatr"},{"issue":"7","key":"443_CR68","first-page":"e125","volume":"1","author":"OJ Veatch","year":"2015","unstructured":"Veatch OJ, Goldman SE, Adkins KW, Malow BA. Melatonin in children with autism spectrum disorders: how does the evidence fit together? J Nat Sci. 2015;1(7):e125.","journal-title":"J Nat Sci"},{"issue":"8","key":"443_CR69","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.jaac.2013.06.001","volume":"52","author":"S Cortese","year":"2013","unstructured":"Cortese S, Brown TE, Corkum P, Gruber R, O\u2019Brien LM, Stein M, et al. Assessment and management of sleep problems in youths with attention-deficit\/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2013;52(8):784\u201396. doi: 10.1016\/j.jaac.2013.06.001 .","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"Suppl 2","key":"443_CR70","doi-asserted-by":"publisher","first-page":"S98","DOI":"10.1542\/peds.2015-2851H","volume":"137","author":"BA Malow","year":"2016","unstructured":"\u2022 Malow BA, Katz T, Reynolds AM, Shui A, Carno M, Connolly HV, et al. Sleep difficulties and medications in children with autism spectrum disorders: a registry study. Pediatrics. 2016;137 Suppl 2:S98\u2013S104. doi: 10.1542\/peds.2015-2851H . Sleep difficulties in ASD are well-addressed in this study.","journal-title":"Pediatrics"},{"issue":"Suppl 1","key":"443_CR71","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1542\/peds.2009-1878D","volume":"125","author":"T Buie","year":"2010","unstructured":"Buie T, Fuchs GJ, III Furuta GT, Kooros K, Levy J, Lewis JD, et al. Recommendations for evaluation and treatment of common gastrointestinal problems in children with ASDs. Pediatrics. 2010;125 Suppl 1:S19\u201329. doi: 10.1542\/peds.2009-1878D .","journal-title":"Pediatrics"},{"issue":"5","key":"443_CR72","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.clinthera.2015.04.001","volume":"37","author":"T Buie","year":"2015","unstructured":"\u2022 Buie T. Potential etiologic factors of microbiome disruption in autism. Clin Ther. 2015;37(5):976\u201383. doi: 10.1016\/j.clinthera.2015.04.001 . This is an excellent review of the microbiome in ASD by an expert in the field.","journal-title":"Clin Ther"},{"issue":"3","key":"443_CR73","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.spen.2013.10.008","volume":"20","author":"A Legido","year":"2013","unstructured":"\u2022 Legido A, Jethva R, Goldenthal MJ. Mitochondrial dysfunction in autism. Semin Pediatr Neurol. 2013;20(3):163\u201375. doi: 10.1016\/j.spen.2013.10.008 . Mitochondrial dysfunction is nicely reviewed in this paper.","journal-title":"Semin Pediatr Neurol"},{"issue":"6","key":"443_CR74","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1542\/peds.2007-0391","volume":"120","author":"RH Haas","year":"2007","unstructured":"Haas RH, Parikh S, Falk MJ, Saneto RP, Wolf NI, Darin N, et al. Mitochondrial disease: a practical approach for primary care physicians. Pediatrics. 2007;120(6):1326\u201333. doi: 10.1542\/peds.2007-0391 .","journal-title":"Pediatrics"},{"issue":"3","key":"443_CR75","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s10803-015-2619-y","volume":"46","author":"N Brondino","year":"2016","unstructured":"Brondino N, Fusar-Poli L, Panisi C, Damiani S, Barale F, Politi P. Pharmacological modulation of GABA function in autism spectrum disorders: a systematic review of human studies. J Autism Dev Disord. 2016;46(3):825\u201339. doi: 10.1007\/s10803-015-2619-y .","journal-title":"J Autism Dev Disord"},{"key":"443_CR76","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2015.0146","author":"MG Aman","year":"2016","unstructured":"Aman MG, Findling RL, Hardan AY, Hendren RL, Melmed RD, Kehinde-Nelson O, et al. Safety and efficacy of memantine in children with autism: randomized, placebo-controlled study and open-label extension. J Child Adolesc Psychopharmacol. 2016. doi: 10.1089\/cap.2015.0146 .","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"4","key":"443_CR77","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1089\/cap.2010.0121","volume":"21","author":"AW Buckley","year":"2011","unstructured":"Buckley AW, Sassower K, Rodriguez AJ, Jennison K, Wingert K, Buckley J, et al. An open label trial of donepezil for enhancement of rapid eye movement sleep in young children with autism spectrum disorders. J Child Adolesc Psychopharmacol. 2011;21(4):353\u20137. doi: 10.1089\/cap.2010.0121 .","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"7","key":"443_CR78","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1177\/0269881113508830","volume":"28","author":"A Ghaleiha","year":"2014","unstructured":"Ghaleiha A, Ghyasvand M, Mohammadi MR, Farokhnia M, Yadegari N, Tabrizi M, et al. Galantamine efficacy and tolerability as an augmentative therapy in autistic children: a randomized, double-blind, placebo-controlled trial. J Psychopharmacol. 2014;28(7):677\u201385. doi: 10.1177\/0269881113508830 .","journal-title":"J Psychopharmacol"},{"issue":"3","key":"443_CR79","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/08830738040190033001","volume":"19","author":"MG Chez","year":"2004","unstructured":"Chez MG, Aimonovitch M, Buchanan T, Mrazek S, Tremb RJ. Treating autistic spectrum disorders in children: utility of the cholinesterase inhibitor rivastigmine tartrate. J Child Neurol. 2004;19(3):165\u20139.","journal-title":"J Child Neurol"},{"issue":"7","key":"443_CR80","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s00213-015-4199-0","volume":"233","author":"RM Zamzow","year":"2016","unstructured":"\u2022 Zamzow RM, Ferguson BJ, Stichter JP, Porges EC, Ragsdale AS, Lewis ML, et al. Effects of propranolol on conversational reciprocity in autism spectrum disorder: a pilot, double-blind, single-dose psychopharmacological challenge study. Psychopharmacology (Berl). 2016;233(7):1171\u20138. doi: 10.1007\/s00213-015-4199-0 . In this study, the authors offer an unusual approach to cognition and treatment in ASD using propranolol.","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"443_CR81","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.pediatrneurol.2014.09.017","volume":"52","author":"A Ghanizadeh","year":"2015","unstructured":"Ghanizadeh A, Ayoobzadehshirazi A. A randomized double-blind placebo-controlled clinical trial of adjuvant buspirone for irritability in autism. Pediatr Neurol. 2015;52(1):77\u201381. doi: 10.1016\/j.pediatrneurol.2014.09.017 .","journal-title":"Pediatr Neurol"},{"issue":"2","key":"443_CR82","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1089\/cap.2013.0040","volume":"24","author":"A Preti","year":"2014","unstructured":"\u2022 Preti A, Melis M, Siddi S, Vellante M, Doneddu G, Fadda R. Oxytocin and autism: a systematic review of randomized controlled trials. J Child Adolesc Psychopharmacol. 2014;24(2):54\u201368. doi: 10.1089\/cap.2013.0040 . Many questions regarding oxytocin in ASD are addressed in this paper.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"23","key":"443_CR83","doi-asserted-by":"publisher","first-page":"8637","DOI":"10.1073\/pnas.1319810111","volume":"111","author":"R Mottolese","year":"2014","unstructured":"Mottolese R, Redoute J, Costes N, Le Bars D, Sirigu A. Switching brain serotonin with oxytocin. Proc Natl Acad Sci U S A. 2014;111(23):8637\u201342. doi: 10.1073\/pnas.1319810111 .","journal-title":"Proc Natl Acad Sci U S A"},{"key":"443_CR84","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.neubiorev.2016.01.001","volume":"63","author":"J Costales","year":"2016","unstructured":"Costales J, Kolevzon A. The therapeutic potential of insulin-like growth factor-1 in central nervous system disorders. Neurosci Biobehav Rev. 2016;63:207\u201322. doi: 10.1016\/j.neubiorev.2016.01.001 .","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"443_CR85","doi-asserted-by":"publisher","first-page":"321","DOI":"10.2217\/bmm.13.158","volume":"8","author":"RE Frye","year":"2014","unstructured":"Frye RE, James SJ. Metabolic pathology of autism in relation to redox metabolism. Biomark Med. 2014;8(3):321\u201330. doi: 10.2217\/bmm.13.158 .","journal-title":"Biomark Med"},{"key":"443_CR86","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.biochi.2016.02.012","volume":"126","author":"A Desai","year":"2016","unstructured":"Desai A, Sequeira JM, Quadros EV. The metabolic basis for developmental disorders due to defective folate transport. Biochimie. 2016;126:31\u201342. doi: 10.1016\/j.biochi.2016.02.012 .","journal-title":"Biochimie"},{"key":"443_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2016.168","author":"RE Frye","year":"2016","unstructured":"\u2022\u2022 Frye RE, Slattery J, Delhey L, Furgerson B, Strickland T, Tippett M, et al. Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial. Mol Psychiatry. 2016. doi: 10.1038\/mp.2016.168 . This important recent clinical trial of folinic acid shows promise for treatment of ASD.","journal-title":"Mol Psychiatry"},{"issue":"9","key":"443_CR88","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1089\/cap.2015.0159","volume":"26","author":"RL Hendren","year":"2016","unstructured":"Hendren RL, James SJ, Widjaja F, Lawton B, Rosenblatt A, Bent S. Randomized, placebo-controlled trial of methyl B12 for children with autism. J Child Adolesc Psychopharmacol. 2016;26(9):774\u201383. doi: 10.1089\/cap.2015.0159 .","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"5","key":"443_CR89","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1089\/cap.2012.0127","volume":"23","author":"C Klaiman","year":"2013","unstructured":"Klaiman C, Huffman L, Masaki L, Elliott GR. Tetrahydrobiopterin as a treatment for autism spectrum disorders: a double-blind, placebo-controlled trial. J Child Adolesc Psychopharmacol. 2013;23(5):320\u20138. doi: 10.1089\/cap.2012.0127 .","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"443_CR90","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.neubiorev.2015.04.015","volume":"55","author":"Deepmala","year":"2015","unstructured":"Deepmala, Slattery J, Kumar N, Delhey L, Berk M, Dean O, et al. Clinical trials of N-acetylcysteine in psychiatry and neurology: a systematic review. Neurosci Biobehav Rev. 2015;55:294\u2013321. doi: 10.1016\/j.neubiorev.2015.04.015 .","journal-title":"Neurosci Biobehav Rev"},{"key":"443_CR91","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13229-016-0088-6","volume":"7","author":"LK Wink","year":"2016","unstructured":"Wink LK, Adams R, Wang Z, Klaunig JE, Plawecki MH, Posey DJ, et al. A randomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder. Mol Autism. 2016;7:26. doi: 10.1186\/s13229-016-0088-6 .","journal-title":"Mol Autism"},{"issue":"3","key":"443_CR92","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jsps.2012.10.001","volume":"21","author":"AS Alanazi","year":"2013","unstructured":"Alanazi AS. The role of nutraceuticals in the management of autism. Saudi Pharm J. 2013;21(3):233\u201343. doi: 10.1016\/j.jsps.2012.10.001 .","journal-title":"Saudi Pharm J"},{"issue":"3","key":"443_CR93","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s12017-016-8430-x","volume":"18","author":"P Rangarajan","year":"2016","unstructured":"Rangarajan P, Karthikeyan A, Dheen ST. Role of dietary phenols in mitigating microglia-mediated neuroinflammation. Neuromolecular Med. 2016;18(3):453\u201364. doi: 10.1007\/s12017-016-8430-x .","journal-title":"Neuromolecular Med"},{"key":"443_CR94","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.lfs.2015.09.012","volume":"141","author":"R Bhandari","year":"2015","unstructured":"Bhandari R, Kuhad A. Neuropsychopharmacotherapeutic efficacy of curcumin in experimental paradigm of autism spectrum disorders. Life Sci. 2015;141:156\u201369. doi: 10.1016\/j.lfs.2015.09.012 .","journal-title":"Life Sci"},{"issue":"5","key":"443_CR95","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.clinthera.2013.04.006","volume":"35","author":"A Taliou","year":"2013","unstructured":"\u2022 Taliou A, Zintzaras E, Lykouras L, Francis K. An open-label pilot study of a formulation containing the anti-inflammatory flavonoid luteolin and its effects on behavior in children with autism spectrum disorders. Clin Ther. 2013;35(5):592\u2013602. doi: 10.1016\/j.clinthera.2013.04.006 . Luteolin offers a potential treatment for ASD that appears to be nontoxic.","journal-title":"Clin Ther"},{"issue":"43","key":"443_CR96","doi-asserted-by":"publisher","first-page":"15550","DOI":"10.1073\/pnas.1416940111","volume":"111","author":"K Singh","year":"2014","unstructured":"\u2022 Singh K, Connors SL, Macklin EA, Smith KD, Fahey JW, Talalay P, et al. Sulforaphane treatment of autism spectrum disorder (ASD). Proc Natl Acad Sci U S A. 2014;111(43):15550\u20135. doi: 10.1073\/pnas.1416940111 . Sulforaphane shows benefit for ASD in this clinical trial, and may provide clues to underlying cellular mechanisms.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"443_CR97","doi-asserted-by":"crossref","first-page":"602","DOI":"10.2174\/1871527315666160413120414","volume":"15","author":"H Liu","year":"2016","unstructured":"Liu H, Talalay P, Fahey JW. Biomarker-guided strategy for treatment of autism spectrum disorder (ASD). CNS Neurol Disord Drug Targets. 2016;15(5):602\u201313.","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"1","key":"443_CR98","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.chc.2014.09.004","volume":"24","author":"SE Levy","year":"2015","unstructured":"\u2022 Levy SE, Hyman SL. Complementary and alternative medicine treatments for children with autism spectrum disorders. Child Adolesc Psychiatr Clin N Am. 2015;24(1):117\u201343. doi: 10.1016\/j.chc.2014.09.004 . This paper is important for its coverage of nontraditional approaches to ASD.","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"443_CR99","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3389\/fped.2014.00087","volume":"2","author":"DA Rossignol","year":"2014","unstructured":"Rossignol DA, Frye RE. The use of medications approved for Alzheimer\u2019s disease in autism spectrum disorder: a systematic review. Front Pediatr. 2014;2:87. doi: 10.3389\/fped.2014.00087 .","journal-title":"Front Pediatr"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-017-0443-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-017-0443-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-017-0443-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T22:00:48Z","timestamp":1750024848000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-017-0443-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":99,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["443"],"URL":"https:\/\/doi.org\/10.1007\/s11940-017-0443-8","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2]]},"article-number":"6"}}